Prescription drug · NDA AUTHORIZED GENERIC
prednisolone sodium phosphate ODT (Prednisolone sodium phosphate) NDC 50742-385
Prednisolone sodium phosphate 30 mg/1 · Tablet, Orally disintegrating · Oral · Ingenus Pharmaceuticals, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50742-385-12 | 5074203851250742038512 | 2 BLISTER PACK in 1 CARTON (50742-385-12) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50742-385-06)Marketed from Sep 15, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- prednisolone sodium phosphate ODTSuffix: ODT
- Generic name (nonproprietary)
- prednisolone sodium phosphate
- Active ingredients
- Prednisolone sodium phosphate — 30 mg/1
- Dosage form
- Tablet, Orally disintegrating
- Route
- Oral
- Labeler
- Ingenus Pharmaceuticals, LLCNDC labeler code 50742
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 021959
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 50742-385_ebbc1751-9381-4db1-89ff-ae5a2963fb2cSPL ID ebbc1751-9381-4db1-89ff-ae5a2963fb2cSPL set ID ebbc1751-9381-4db1-89ff-ae5a2963fb2cRxCUI 643123, 643125, 643127UNII IV021NXA9J
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450742038512followed by a unit qualifier and the quantityPackage 50742-0385-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Prednisolone sodium phosphate orally disintegrating tablets are indicated in the treatment of the following diseases or conditions: Prednisolone sodium phosphate orally disintegrating tablet is a corticosteroid indicated as an anti-inflammatory or immunosuppressive agent for certain allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, specific infectious diseases or conditions and organ transplantation (1) for the treatment of certain endocrine conditions (1) for palliation of certain neoplastic conditions (1) 1.1 Allergic Conditions Control of severe or incapacitating allergic conditions intractable to adequate trials of c…
Excerpt only. Read the full label for complete information.
About NDC 50742-385
- What is NDC 50742-385?
- 50742-385 is the product NDC for prednisolone sodium phosphate ODT, Prednisolone sodium phosphate 30 mg/1 tablet, orally disintegrating, listed with the FDA by Ingenus Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- prednisolone sodium phosphate ODT (Prednisolone sodium phosphate).
- What is the active ingredient?
- Prednisolone sodium phosphate.
- Who is the labeler?
- Ingenus Pharmaceuticals, LLC, NDC labeler code 50742. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for prednisolone sodium phosphate ODT?
- 2 other product NDCs are listed under this name. See all prednisolone sodium phosphate ODT NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other prednisolone sodium phosphate ODT products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| prednisolone sodium phosphate ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 10 mg/1 | Tablet, Orally disintegratingOral | Ingenus Pharmaceuticals, LLC | 50742-383 | 50742-0383-12 |
| prednisolone sodium phosphate ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 15 mg/1 | Tablet, Orally disintegratingOral | Ingenus Pharmaceuticals, LLC | 50742-384 | 50742-0384-12 |
Other NDCs under NDA 021959
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Orapred ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 10 mg/1 | Tablet, Orally disintegratingOral | Advanz Pharma (US) Corp. | 59212-700 |
| Orapred ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 15 mg/1 | Tablet, Orally disintegratingOral | Advanz Pharma (US) Corp. | 59212-701 |
| Orapred ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 30 mg/1 | Tablet, Orally disintegratingOral | Advanz Pharma (US) Corp. | 59212-702 |
| prednisolone sodium phosphate ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 10 mg/1 | Tablet, Orally disintegratingOral | Ingenus Pharmaceuticals, LLC | 50742-383 |
| prednisolone sodium phosphate ODTprednisolone sodium phosphate | Prednisolone sodium phosphate 15 mg/1 | Tablet, Orally disintegratingOral | Ingenus Pharmaceuticals, LLC | 50742-384 |